FdaApplication
NDA 022511
Identifiers
- fda_app_no: NDA022511
Properties
| Property | Value |
|---|---|
| applicant_name | HORIZON MEDICINES LLC |
| application_type | NDA |
| approval_date | 2010-04-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VIMOVO | ESOMEPRAZOLE MAGNESIUM; NAPROXEN | EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, DELAYED RELEASE;ORAL |
| VIMOVO | ESOMEPRAZOLE MAGNESIUM; NAPROXEN | EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, DELAYED RELEASE;ORAL |
2 products